Home/Filings/4/0001209191-20-045106
4//SEC Filing

Schneider Jennifer 4

Accession 0001209191-20-045106

CIK 0001639225other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:25 PM ET

Size

36.1 KB

Accession

0001209191-20-045106

Insider Transaction Report

Form 4
Period: 2020-08-03
Transactions
  • Sale

    Common Stock

    2020-08-03$130.56/sh1,600$208,891220,629 total
  • Sale

    Common Stock

    2020-08-03$131.41/sh3,397$446,385217,232 total
  • Sale

    Common Stock

    2020-08-03$133.24/sh303$40,371216,329 total
  • Sale

    Common Stock

    2020-08-04$141.54/sh1,700$240,611218,629 total
  • Sale

    Common Stock

    2020-08-04$142.37/sh900$128,137217,729 total
  • Sale

    Common Stock

    2020-08-04$147.32/sh100$14,732216,329 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-08-046,700584,868 total
    Exercise: $0.80Exp: 2025-09-02Common Stock (6,700 underlying)
  • Sale

    Common Stock

    2020-08-03$129.72/sh800$103,780222,229 total
  • Exercise/Conversion

    Common Stock

    2020-08-03$0.80/sh+6,700$5,360223,029 total
  • Sale

    Common Stock

    2020-08-04$138.74/sh400$55,497222,629 total
  • Sale

    Common Stock

    2020-08-04$140.48/sh1,400$196,670220,329 total
  • Sale

    Common Stock

    2020-08-04$144.66/sh100$14,466217,229 total
  • Sale

    Common Stock

    2020-08-04$146.50/sh800$117,198216,429 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-08-036,700591,568 total
    Exercise: $0.80Exp: 2025-09-02Common Stock (6,700 underlying)
  • Sale

    Common Stock

    2020-08-03$132.54/sh600$79,524216,632 total
  • Exercise/Conversion

    Common Stock

    2020-08-04$0.80/sh+6,700$5,360223,029 total
  • Sale

    Common Stock

    2020-08-04$139.78/sh900$125,799221,729 total
  • Sale

    Common Stock

    2020-08-04$143.62/sh400$57,448217,329 total
Footnotes (14)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.105 to $141.72, inclusive.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.145 to $142.74, inclusive.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.50 to $143.90, inclusive.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.07 to $146.99, inclusive.
  • [F14]One-fourth of the shares subject to the option vested on September 1, 2016 and 1/48 of the shares vest monthly thereafter.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.00 to $129.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (13) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.24 to $130.90, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.02 to $131.85, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.06 to $132.715, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.025 to $133.64, inclusive.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.72 to $138.81, inclusive.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.405 to $139.98, inclusive.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.11 to $140.97, inclusive.

Issuer

Livongo Health, Inc.

CIK 0001639225

Entity typeother

Related Parties

1
  • filerCIK 0001783060

Filing Metadata

Form type
4
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:25 PM ET
Size
36.1 KB